Future Retail [FRETAIL] vs Astal Laboratories [ASTALLTD] Detailed Stock Comparison
Future Retail
NSE
Loading...
Astal Laboratories
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Future Retail wins in 10 metrics, Astal Laboratories wins in 8 metrics, with 0 ties. Future Retail appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Future Retail | Astal Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.04 | 10.84 | Future Retail |
| Price-to-Book Ratio | -0.10 | 2.38 | Future Retail |
| Debt-to-Equity Ratio | -12.67 | 36.86 | Future Retail |
| PEG Ratio | 0.00 | 0.45 | Future Retail |
| EV/EBITDA | -5.22 | 7.55 | Future Retail |
| Profit Margin (TTM) | -52.09% | 12.33% | Astal Laboratories |
| Operating Margin (TTM) | -25.44% | 11.14% | Astal Laboratories |
| EBITDA Margin (TTM) | N/A | 11.14% | N/A |
| Return on Equity | -291.62% | 24.80% | Astal Laboratories |
| Return on Assets (TTM) | -16.76% | 14.09% | Astal Laboratories |
| Free Cash Flow (TTM) | $-1.87B | $-182.92M | Astal Laboratories |
| 1-Year Return | 0.00% | -11.22% | Future Retail |
| Price-to-Sales Ratio (TTM) | 0.01 | 1.24 | Future Retail |
| Enterprise Value | $154.83B | $974.12M | Future Retail |
| EV/Revenue Ratio | 1.83 | 1.29 | Astal Laboratories |
| Gross Profit Margin (TTM) | 17.63% | 15.24% | Future Retail |
| Revenue per Share (TTM) | $156 | $77 | Future Retail |
| Earnings per Share (Diluted) | $-65.16 | $8.06 | Astal Laboratories |
| Beta (Stock Volatility) | 0.91 | -0.84 | Astal Laboratories |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Future Retail vs Astal Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Future Retail | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Astal Laboratories | 5.27% | 9.05% | 13.43% | 7.87% | 11.05% | 17.39% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Future Retail | 0.00% | -39.20% | -97.09% | -98.51% | -98.51% | -98.51% |
| Astal Laboratories | -11.22% | 104.90% | 104.90% | 104.90% | 104.90% | 104.90% |
News Based Sentiment: Future Retail vs Astal Laboratories
Future Retail
News based Sentiment: NEGATIVE
The month of October was dominated by asset liquidation efforts for Future Retail Ltd., specifically the auction of trademarks and brands. This, combined with a static stock price, indicates continued financial distress and limited positive developments for investors.
Astal Laboratories
News based Sentiment: NEUTRAL
The month began with a stable trading day for Astal Laboratories, showing a slight increase in share price and consistent activity. While positive, the movement was not significant enough to indicate a major shift in the company's investment outlook, resulting in a neutral overall assessment.
Performance & Financial Health Analysis: Future Retail vs Astal Laboratories
| Metric | FRETAIL | ASTALLTD |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.30B | ₹954.61M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 63,719 | 16,404 |
| 90 Day Avg. Volume | 21,240 | 16,065 |
| Last Close | ₹2.28 | ₹97.20 |
| 52 Week Range | ₹2.28 - ₹2.28 | ₹66.72 - ₹101.37 |
| % from 52W High | 0.00% | -4.11% |
| All-Time High | ₹638.61 (Nov 20, 2017) | ₹131.70 (Sep 09, 2024) |
| % from All-Time High | -99.64% | -26.20% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.87% | 0.91% |
| Quarterly Earnings Growth | 0.87% | 0.24% |
| Financial Health | ||
| Profit Margin (TTM) | -0.52% | 0.12% |
| Operating Margin (TTM) | -0.25% | 0.11% |
| Return on Equity (TTM) | -2.92% | 0.25% |
| Debt to Equity (MRQ) | -12.67 | 36.86 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹-22.51 | ₹36.75 |
| Cash per Share (MRQ) | ₹1.85 | ₹1.76 |
| Operating Cash Flow (TTM) | ₹-3,108,300,000 | ₹-116,989,000 |
| Levered Free Cash Flow (TTM) | ₹-31,895,200,000 | ₹89.25M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Future Retail vs Astal Laboratories
| Metric | FRETAIL | ASTALLTD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.04 | 10.84 |
| Forward P/E | 0.12 | N/A |
| PEG Ratio | 0.00 | 0.45 |
| Price to Sales (TTM) | 0.01 | 1.24 |
| Price to Book (MRQ) | -0.10 | 2.38 |
| Market Capitalization | ||
| Market Capitalization | ₹1.30B | ₹954.61M |
| Enterprise Value | ₹154.83B | ₹974.12M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.83 | 1.29 |
| Enterprise to EBITDA | -5.22 | 7.55 |
| Risk & Other Metrics | ||
| Beta | 0.91 | -0.84 |
| Book Value per Share (MRQ) | ₹-22.51 | ₹36.75 |
Financial Statements Comparison: Future Retail vs Astal Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FRETAIL | ASTALLTD |
|---|---|---|
| Revenue/Sales | ₹28.16B | ₹253.27M |
| Cost of Goods Sold | ₹23.19B | ₹214.66M |
| Gross Profit | ₹4.97B | ₹38.61M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-7.30B | ₹30.38M |
| EBITDA | ₹-3.10B | ₹32.14M |
| Pre-Tax Income | ₹-10.63B | ₹27.93M |
| Income Tax | N/A | ₹7.03M |
| Net Income (Profit) | ₹-10.63B | ₹20.90M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FRETAIL | ASTALLTD |
|---|---|---|
| Cash & Equivalents | ₹613.00M | ₹17.30M |
| Total Current Assets | ₹97.76B | ₹456.39M |
| Total Current Liabilities | ₹141.43B | ₹267.71M |
| Long-Term Debt | ₹47.21B | ₹4.56M |
| Total Shareholders Equity | ₹-12.21B | ₹359.95M |
| Retained Earnings | N/A | ₹107.05M |
| Property, Plant & Equipment | ₹56.51B | ₹0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FRETAIL | ASTALLTD |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FRETAIL | ASTALLTD |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 63,719 | 16,404 |
| Average Daily Volume (90 Day) | 21,240 | 16,065 |
| Shares Outstanding | 542.28M | 9.83M |
| Float Shares | 536.78M | 4.51M |
| % Held by Insiders | 0.00% | 0.51% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Future Retail vs Astal Laboratories
| Metric | FRETAIL | ASTALLTD |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |